Cisplatin versus doxorubicin/cyclophosphamide as neoadjuvant treatment in germli...
Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA
19 Dec 2019
Breast cancer screening and treatment in Brazil
Dr Gustavo Werutsky - Latin American Cooperative Oncology Group, Porto Alegre, B...
19 Dec 2019
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive b...
Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
19 Dec 2019
Long-term influence of oestrogen plus progestin vs oestrogen alone on breast can...
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
19 Dec 2019
Residual cancer burden after neoadjuvant therapy and long-term survival outcomes...
Prof William Symmans - MD Anderson Cancer Center, Houston, Texas
19 Dec 2019
Circulating tumour DNA used to predict disease recurrence for early triple-negat...
Dr Milan Radovich - Indiana University Melvin and Bren Simon Cancer Center, Indi...
19 Dec 2019
Oral paclitaxel with encequidar in metastatic breast cancer
Dr Gerardo Umanzor - Hospital del Valle, San Pedro Sula, Honduras
19 Dec 2019
Pathologic complete response rates improved with the neoadjuvant and adjuvant tr...
Prof Peter Schmid - St Bartholomew's Hospital London, London, UK
18 Dec 2019
Combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic c...
Dr Luca Gianni - San Raffaele Hospital, Milan, Italy
18 Dec 2019
Breast cancer prevention in high-risk post-menopausal women
Prof Jack Cuzick - Queen Mary University of London, London, UK
18 Dec 2019
Accelerated partial breast irradiation versus whole breast irradiation in patien...
Dr Icro Meattini - Univerity of Florence, Florence, Italy
18 Dec 2019
Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the...
Dr Luca Gianni - San Raffaele Hospital, Milan, Italy
18 Dec 2019
